Evidence map›Paper›PMID 37513279›Full record

ReviewMolecules (Basel, Switzerland)2023

Recent Developments and Applications of Microbial Levan, A Versatile Polysaccharide-Based Biopolymer.

Marta Domżał-Kędzia, Monika Ostrowska, Agnieszka Lewińska, Marcin Łukaszewicz

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
15.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Fabrication of levan derived fromSynthetic and systems biotechnology · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Optimization of levan biosynthesis fromBiotechnology reports (Amsterdam, Netherlands) · 2025
    Article
  15. Molecular Basis ofJournal of agricultural and food chemistry · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Life (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Marta Domżał-KędziaFaculty of Biotechnology, University of Wroclaw, Joliot Curie 14a, 50-383 Wroclaw, Poland.ORCID 0000-0002-4001-9983
Monika OstrowskaResearch and Development Department InventionBio S.A., Jakóba Hechlińskiego 4, 85-825 Bydgoszcz, Poland.
Agnieszka LewińskaFaculty of Chemistry, University of Wroclaw, Joliot Curie 14, 50-383 Wroclaw, Poland.ORCID 0000-0001-9821-8793
Marcin ŁukaszewiczFaculty of Biotechnology, University of Wroclaw, Joliot Curie 14a, 50-383 Wroclaw, Poland.ORCID 0000-0002-1453-8376
University of Wrocław · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polysaccharides are essential components with diverse functions in living organisms and find widespread applications in various industries. They serve as food additives, stabilizers, thickeners, and fat substitutes in the food industry, while also contributing to dietary fiber for improved digestion and gut health. Plant-based polysaccharides are utilized in paper, textiles, wound dressings, biodegradable packaging, and tissue regeneration. Polysaccharides play a crucial role in medicine, pharmacy, and cosmetology, as well as in the production of biofuels and biomaterials. Among microbial biopolymers, microbial levan, a fructose polysaccharide, holds significant promise due to its high productivity and chemical diversity. Levan exhibits a wide range of properties, including film-forming ability, biodegradability, non-toxicity, self-aggregation, encapsulation, controlled release capacity, water retention, immunomodulatory and prebiotic activity, antimicrobial and anticancer activity, as well as high biocompatibility. These exceptional properties position levan as an attractive candidate for nature-based materials in food production, modern cosmetology, medicine, and pharmacy. Advancing the understanding of microbial polymers and reducing production costs is crucial to the future development of these fields. By further exploring the potential of microbial biopolymers, particularly levan, we can unlock new opportunities for sustainable materials and innovative applications that benefit various industries and contribute to advancements in healthcare, environmental conservation, and biotechnology.

Indexed as

Anti-Infective AgentsPolymersBiopolymersBiotechnologyFructansAnti-Infective AgentsBiopolymersFructansPolymersBacillus subtilisbiopolymerscosmeticsfood industrieslevanpharmaceutical industriespolysaccharidesafety

Identifiers

PMID37513279
PMCPMC10384002
OpenAlexW4384339270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.